Literature DB >> 17323193

Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan.

T Kawai1, K Miki, M Ichinose, Y Kenji, I Miyazaki, K Kawakami, M Kataoka, T Yamagishi, A Sofuni, T Itoi, F Moriyasu, Y Takagi, T Aoki, J Matsubayashi, K Mukai.   

Abstract

AIMS: The pepsinogen (PG) test result is used in Japan for screening for gastric cancer. In this study, we investigated the changes in evaluation of the PG test result following H. pylori eradication.
METHODS: The subjects were 120 consecutive H. pylori-positive patients with upper gastrointestinal symptoms. Subjects underwent endoscopy prior to, and at 2 months after the eradication therapy, at which time blood was taken for determination of changes in PG levels.
RESULTS: The overall eradication rate was 79.3% (per protocol). Following eradication therapy, the evaluation of PG test result converted from positive to negative in 80.4% (37/46) of cases of successful eradication, and in 0% (0/6) of cases of eradication failure.
CONCLUSIONS: These results suggest that the evaluation of PG test result should be used after the definitive confirmation of the success or failure of H. pylori eradication therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17323193     DOI: 10.1007/s10787-006-0009-y

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  6 in total

1.  Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among Group A subjects of ABC classification: a multicenter study.

Authors:  Daisuke Chinda; Tadashi Shimoyama; Tatsuya Mikami; Tetsu Arai; Daisuke Chiba; Yoshio Sasaki; Kazuo Komai; Yoshihiko Sawada; Yoshiharu Saito; Hironobu Chiba; Shinsaku Fukuda
Journal:  J Gastroenterol       Date:  2018-01-20       Impact factor: 7.527

Review 2.  Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

Authors:  David Y Graham
Journal:  Gastroenterology       Date:  2015-02-02       Impact factor: 22.682

3.  Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.

Authors:  Mitsuru Kaise; Jun Miwa; Ai Fujimoto; Jun Tashiro; Daisuke Tagami; Hiromi Sano; Yasukazu Ohmoto
Journal:  Gastric Cancer       Date:  2012-08-21       Impact factor: 7.370

Review 4.  Metachronous gastric cancer after successful Helicobacter pylori eradication.

Authors:  Akiko Shiotani; Ken Haruma; David Y Graham
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 5.  Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

Authors:  Kazumasa Miki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

6.  Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer.

Authors:  A Shiotani; T Murao; Y Kimura; H Matsumoto; T Kamada; H Kusunoki; K Inoue; N Uedo; H Iishi; K Haruma
Journal:  Br J Cancer       Date:  2013-10-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.